Advance On Ventures Limited holds 109,200 Advanced Biomed shares, equal to 6.6% ownership. The structure matters to investors because Chen Yi Lee has sole voting and dispositive power over those shares and also directly holds 14,640 shares, for a reported 7.5% position.

Key Highlights

  • Advanced Biomed’s ownership percentages are based on 1,652,133 common shares outstanding as of May 29, 2026.
  • Chen Yi Lee’s reported position totals 123,840 shares, or 7.5% of Advanced Biomed.
  • Advance On Ventures Limited is organized in the British Virgin Islands and has its principal Business address in Taiwan.

Advanced Biomed Inc. (NASDAQ: ADVB) is a biotechnology company. Advance On Ventures Limited holds 109,200 shares of Advanced Biomed common stock, representing 6.6% ownership.

Ownership Basis and Reporting Parties

The jointly submitted ownership statement identifies Advance On Ventures Limited and Chen Yi Lee as the reporting persons. The percentage calculation uses 1,652,133 Advanced Biomed common shares outstanding as of May 29, 2026, a figure reported in the company’s definitive proxy statement filed June 4, 2026. The security is common stock with a Par Value of $0.001 per share. Advance On Ventures Limited was organized in the British Virgin Islands, while its principal business address and Chen Yi Lee’s principal business address are in Taiwan.

Chen Yi Lee Holds Voting Control

Advance On Ventures Limited is the registered holder of its reported shares, and Chen Yi Lee has sole voting and dispositive authority over that holding as the company’s sole director. Chen Yi Lee also owns 14,640 Advanced Biomed shares directly, consisting of 14,625 shares acquired before the initial public offering and 15 shares bought in the open market afterward. The combined reported position is 123,840 shares, equal to 7.5% ownership. The ownership statement was submitted under Rule 13d-1(d).